Broad-spectrum polysynthetic penicillins, for example, ampicillin and geta-cillin, inhibit the growth of the intestinal, typhoid, and dysentery bacilli. The prolonged and widespread use of antibiotics resulted in the appearance of a great many pathogenic microorganisms resistant to them. A matter of ...
Human infections caused by cestodes, or tapeworms, may occur within the lumen of the bowel, where adult cestodes attach themselves to the host intestine (Box 1). Alternatively, human infection may be the result of dissemination of cestodes from the bowel to involve extraintestinal sites, often ...
Antibiotics for the treatment of colon or prevention of intestinal inflammation after infectionMethods to reduce the chance of getting the post infectious IBS (pi-ibs) by administration of an antibiotic.PIMENTEL MARK , CHANG CHRISTOPHER.
which is normally found in the body, and the invading disease-causing bacteria. This can cause a disturbance in the normal body balance, especially throughout the gastro-intestinal tract. Side effects of this imbalance
This review evaluates the current literature based on the impact of antibiotics on the intestinal microbiota and the critical role of intestinal bacteria in controlling infection and subsequent clinical disease caused by STEC and Salmonella, and the transmissibility of these important pathogens.A number ...
Natural Antibiotics: Foods that Work as Antibiotics Antibiotics Won't Help Cure Your Flu Or Cold: Here's Why You Shouldn't Ask For Them! Probiotics Plus Antibiotics For Chronic Intestinal Infection When Does The Birth Control Pill Start Working? View more Remove...
- 《Infection & Immunity》 被引量: 78发表: 1980年 Growth of Enterococcus faecalis (Streptococcus faecalis) BIO-4R in the Intestinal Tract of Animals and Humans Enterococcus faecalis BIO-4R (BIO-4R) showed a decreased growth rate in ACY broth as compared with its parental strain, BIO, but...
Graft-vs-Host Patients undergoing allogeneic hematopoietic stem cell transplantation often receive antibiotics for infections, which unfortunately also kill intestinal bacteria. These symbiotic bacteria in the gut do not normally cause disease and are thought to suppress inflammation. Shono et al.DOI...
Finding the right antibiotic dose is akin to a Goldilocks problem: give too little, and the infection will persist; too much, and side-effects will override the benefits of the therapy. To get it “just right”, Prof Dr Birgit Koch talks about dosing optimisation in the clinical setting. ...
Fidaxomicin (1) was developed by Optimer Pharmaceuticals (San Diego, CA, USA) and approved by the US FDA in May 2011 (trade name: Dificid) and by the EMA in December 2011 (trade name: Dificlir) for the treatment of intestinal infections and diarrhea caused by C. difficile.41 C. ...